site:www.pharmexec.com - Search Videos

Why is the Failure Rate for DCTs so High? | PharmExec

Why is the Failure Rate for DCTs so High? | PharmExec

What Are the ‘Last Mile Issues’ Impacting Pharma? | PharmExec

What Are the ‘Last Mile Issues’ Impacting Pharma? | PharmExec

Surfacing Themes at Access USA 2026 | PharmExec

Surfacing Themes at Access USA 2026 | PharmExec

What Governance Resets Should Pharma Companies Take in Response to AI? | PharmExec

What Governance Resets Should Pharma Companies Take in Respo…

How Does Patient Adherence Impact Both the Science and Finance of Clinical Trials? | PharmExec

How Does Patient Adherence Impact Both the Science and Finance of C…

What Does a Truly Ai-Native Patient Access Infrastructure Look Like in 2026? | PharmExec

What Does a Truly Ai-Native Patient Access Infrastructure Look Like i…

How are the Rare Disease Evidence Principles Reshaping Evidentiary Expectations? | PharmExec

How are the Rare Disease Evidence Principles Reshaping Evidentiary …

What Impact is Innovative CGT Trial Design Having on Sponsors? | Ph…

How Paysign Assists Manufacturers Making the Connection from Copa…

What an End-to-End Model Changes for Patients | PharmExec

How Do Recent Actions from FDA Provide Insight to the Agency's En…

ClipNotes: AI Built for Pharma: Why Out-of-the-Box Beats Build-From-…

Specialty Pharmacists: Evolving from Dispensing Medications to S…

The Influence of Targeting CCR5 Receptors | PharmExec

The Secrets of Successful Drug Launches: The Six Root Causes o…

How is Re-Vana Using its Sustained-Delivery Hydrogel Technology to …

Operational Challenges for Specialty Pharmacies | PharmExec

Reshaping Complex Therapy Delivery | PharmExec

How Veristat is Adapting Its Approach to Clinical Trials | Phar…

What Trends Did You See at This Year's JP Morgan Healthcare Conf…

How Will Recent Regulatory Developments at FDA Impact Feas…

What Successes and Setbacks Occurred in Neurosciences in 202…

Eisai Highlights Long-Term Efficacy of Lenvima in Advanced HCC Trea…

AbbVie Positions Temab-A ADC for Tumor-Agnostic Use in Multiple C…

What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan H…

The Challenges and Advantages of US Healthcare in a Worldwide Per…

What's Causing So Many Phase III Trials to Head for Avoidable Failur…

Understanding the Long-Term Impact of Surgical Adhesions | Ph…

Early Data on ABBV-706 Suggests New Hope for Neuroendocrine Tu…

Lawsuits Likely as Federal Authorities Roll Back Longstandin…

See more videos